Literature DB >> 30279839

Progressive spontaneous coronary artery dissection secondary to fibromuscular dysplasia requiring mechanical circulatory support.

Marta Alonso-Fernández-Gatta1, Aitor Uribarri1, Alejandro Diego-Nieto1, Pedro L Sánchez1.   

Abstract

Spontaneous coronary artery dissection (SCAD) usually appears as an acute coronary syndrome with good prognosis. We present the case of a 39-year-old woman with progressive SCAD secondary to fibromuscular dysplasia with catastrophic course. The patient required several mechanical circulatory support systems including a left ventricular assist device (CentriMag®, Thoratec, Pleasanton, CA, USA) as bridge to recovery. <Learning objective: The beneficial use of mechanical circulatory support devices as a bridge to recovery or heart transplant in the setting of refractory cardiogenic shock in spontaneous coronary artery dissection.>.

Entities:  

Keywords:  Cardiogenic shock; Extracorporeal membrane oxygenation; Heart failure; Spontaneous coronary artery dissection; Ventricular assist devices

Year:  2017        PMID: 30279839      PMCID: PMC6149640          DOI: 10.1016/j.jccase.2017.08.010

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

Review 1.  Spontaneous coronary artery dissection.

Authors:  Christian J M Vrints
Journal:  Heart       Date:  2010-05       Impact factor: 5.994

2.  Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis.

Authors:  Yih-Sharng Chen; Jou-Wei Lin; Hsi-Yu Yu; Wen-Je Ko; Jih-Shuin Jerng; Wei-Tien Chang; Wen-Jone Chen; Shu-Chien Huang; Nai-Hsin Chi; Chih-Hsien Wang; Li-Chin Chen; Pi-Ru Tsai; Sheoi-Shen Wang; Juey-Jen Hwang; Fang-Yue Lin
Journal:  Lancet       Date:  2008-07-04       Impact factor: 79.321

3.  Renal artery fibromuscular dysplasia: in vivo optical coherence tomography insights.

Authors:  Angel Sánchez-Recalde; Raúl Moreno; Santiago Jiménez-Valero
Journal:  Eur Heart J       Date:  2013-08-29       Impact factor: 29.983

Review 4.  Spontaneous coronary artery dissection: novel insights on diagnosis and management.

Authors:  Fernando Alfonso; Teresa Bastante; Javier Cuesta; Daniel Rodríguez; Amparo Benedicto; Fernando Rivero
Journal:  Cardiovasc Diagn Ther       Date:  2015-04

5.  Clinical features of spontaneous coronary artery dissection.

Authors:  Michiaki Tokura; Isao Taguchi; Michiya Kageyama; Takahisa Nasuno; Yoshitaka Nishiyama; Noboru Koshiji; Satoshi Koizumi; Daisuke Uehara; Yukitomo Ogino; Shigeru Toyoda; Shichiro Abe; Teruo Inoue
Journal:  J Cardiol       Date:  2013-09-04       Impact factor: 3.159

Review 6.  European consensus on the diagnosis and management of fibromuscular dysplasia.

Authors:  Alexandre Persu; Alessandra Giavarini; Emmanuel Touzé; Andrzej Januszewicz; Marc Sapoval; Michel Azizi; Xavier Barral; Xavier Jeunemaitre; Alberto Morganti; Pierre-François Plouin; Peter de Leeuw
Journal:  J Hypertens       Date:  2014-07       Impact factor: 4.844

Review 7.  Spontaneous coronary artery dissection.

Authors:  Daniele Giacoppo; Davide Capodanno; George Dangas; Corrado Tamburino
Journal:  Int J Cardiol       Date:  2014-04-26       Impact factor: 4.164

8.  Clinical performance with the Levitronix Centrimag short-term ventricular assist device.

Authors:  F De Robertis; E J Birks; P Rogers; G Dreyfus; J R Pepper; A Khaghani
Journal:  J Heart Lung Transplant       Date:  2006-01-06       Impact factor: 10.247

Review 9.  What Clinicians Should Know Αbout Spontaneous Coronary Artery Dissection.

Authors:  Marysia S Tweet; Rajiv Gulati; Sharonne N Hayes
Journal:  Mayo Clin Proc       Date:  2015-08       Impact factor: 7.616

10.  Spontaneous coronary artery dissection: prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort.

Authors:  Jacqueline Saw; Donald Ricci; Andrew Starovoytov; Rebecca Fox; Christopher E Buller
Journal:  JACC Cardiovasc Interv       Date:  2012-12-19       Impact factor: 11.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.